Technology & Software Global On demand · 24-48h

Global Artificial Intelligence Endoscopy System Market Strategic Research Report

Global Artificial Intelligence Endoscopy System Market Strat…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Artificial Intelligence Endoscopy System Market
$2.2B2025
9.6%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Hardware Devices, Software, Services

By Application: Clinical, Operation, Patient Monitoring, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Medtronic, Olympus, Fujifilm, Wision, PENTAX Medical, Wision A.I., Cybernet Systems, NEC Corporation, Magentiq Eye, AI Medical Service, Iterative Scopes, EndoVigilant, SMART Medical Systems, EndoAngel Medical Technology, Iterative Scopes, EndoSoft

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 124 pages
Market size 2025
$2.2B
Billion USD
Forecast CAGR
9.6%
2025-2032
Forecast 2032
$4.2B
Projected
영역들
5
Asia Pacific · Latin America · MEA · Europe · North America

개요

Scope of the Report

The global Artificial Intelligence Endoscopy System market size is predicted to grow from US$ 2,197 million in 2025 to US$ 4,137 million in 2032; it is expected to grow at a CAGR of 9.6% from 2026 to 2032.

Artificial intelligence endoscopy systems combine artificial intelligence technology with endoscopic technology to enhance diagnostic and surgical capabilities. Through machine learning algorithms, this system can identify lesions, mark important tissues, assist navigation, and even help doctors determine the nature of lesions in real time during endoscopic examinations, thereby improving detection rates and surgical accuracy.

The upstream of the AI endoscopy system industry chain mainly includes high-definition CMOS image sensors, LED light sources, flexible optical fibers, endoscope tube materials, GPU/ASIC acceleration chips, deep learning algorithm frameworks, medical displays, AI inference modules, and image processing software platforms. Key components are supplied by optical material suppliers such as Sony, ON Semiconductor, Lattice, and Lumenis, as well as some AI chip manufacturers. The downstream mainly consists of departments such as gastroenterology, endoscopy centers, respiratory medicine, and general surgery in general hospitals. Gastroenterology endoscopy centers have the largest demand due to the large number of gastrointestinal endoscopy procedures. AI is mainly used for early cancer screening, polyp identification, and mucosal microstructure analysis, which can significantly improve detection rates and reduce differences in surgeon experience. Respiratory medicine is seeing increased demand for AI-based lesion localization and interventional decision support in bronchoscopy, but the overall scale remains small. In general surgery, AI is used in laparoscopic surgery for surgical field identification, tissue boundary segmentation, and risk structure alerts, which can improve surgical safety. However, its adoption is slow due to high equipment prices and strict clinical procedures. Private chain endoscopy centers and health checkup institutions have become the fastest-growing downstream market in recent years. Due to their high reliance on standardized quality control, AI-assisted diagnosis can improve service homogeneity and reduce the risk of misdiagnosis.

The industry's development trend shows an expansion from AI recognition to AI decision-making and AI automation. AI capabilities are extending from polyp identification to end-to-end endoscopic quality control, operation guidance, lesion feature quantification, and intraoperative navigation. Driving factors include the increasing global demand for gastrointestinal cancer screening, rising demand for endoscopy due to aging populations, hospitals' strong demand to reduce missed diagnoses, enhanced real-time analysis capabilities brought about by improved AI chip computing power, and the gradual support of medical insurance systems for early screening of precancerous lesions. Hindering factors include the limited transferability of AI algorithms between different brands of endoscopes, leading to high hospital replacement costs; insufficient algorithm generalization requiring large amounts of labeled data; long regulatory review cycles limiting product iteration speed; high AI system prices affecting adoption rates in primary hospitals; and some doctors' doubts about AI reliance leading to varying clinical acceptance.

Annual production is approximately 1,000–3,000 units, with the industry's gross profit margin generally ranging from 40% to 60%.

This report presents a comprehensive overview of the global Artificial Intelligence Endoscopy System market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Hardware Devices
  • Software
  • Services

Segment by Function

  • CADe (Computer-Aided Detection)
  • CADx (Computer-Aided Diagnosis)
  • Quality / Workflow AI
  • Reporting / Documentation AI

Segment by Deployment Architecture

  • Embedded Type
  • External Module Type
  • Local Server Type
  • Cloud/SaaS Type

Segment by Application

  • Clinical
  • Operation
  • Patient Monitoring
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Artificial Intelligence Endoscopy System market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Clinical, Operation, Patient Monitoring evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Artificial Intelligence Endoscopy System Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 9.6%
Regional growth momentum
Market share by segment
Key metrics
Base value
$2.2B
2025
Forecast
$4.2B
2032
CAGR
9.6%
2025–2032
영역들
5
global
Key companies
MedtronicOlympusFujifilmWisionPENTAX MedicalWision A.I.Cybernet SystemsNEC Corporation
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Hardware DevicesSoftwareServices
By Application
ClinicalOperationPatient MonitoringOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Hardware Devices
  • 3.1.3 Software
  • 3.1.4 Services
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Clinical
  • 4.1.3 Operation
  • 4.1.4 Patient Monitoring
  • 4.1.5 Others
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Medtronic
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Olympus
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Fujifilm
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Wision
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 PENTAX Medical
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Wision A.I.
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Cybernet Systems
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 NEC Corporation
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Magentiq Eye
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 AI Medical Service
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Iterative Scopes
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 EndoVigilant
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 SMART Medical Systems
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 EndoAngel Medical Technology
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Iterative Scopes
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 EndoSoft
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Artificial Intelligence Endoscopy System market size?
The global Artificial Intelligence Endoscopy System market is estimated at US$ 2.2 billion in 2025 (base year) and is projected to reach US$ 4.14 billion by 2032.
What growth rate is expected for the Artificial Intelligence Endoscopy System market through 2032?
The market is expected to grow at a CAGR of 9.6% from 2026 to 2032, expanding from US$ 2.2 billion in 2025 to US$ 4.14 billion in 2032, roughly 1.9 times its base-year value.
How is Artificial Intelligence Endoscopy System defined?
Artificial intelligence endoscopy systems combine artificial intelligence technology with endoscopic technology to enhance diagnostic and surgical capabilities. Through machine learning algorithms, this system can identify lesions, mark important tissues, assist navigation, and even help doctors determine the nature of lesions in real time during endoscopic examinations, thereby improving detection rates and surgical accuracy.
How is the Artificial Intelligence Endoscopy System market segmented by type?
By type, the market is segmented into Hardware Devices, Software and Services.
What are the key applications of Artificial Intelligence Endoscopy System?
Key applications covered include Clinical, Operation, Patient Monitoring and Others.
Which companies are profiled in the Artificial Intelligence Endoscopy System market report?
Key players profiled include Medtronic, Olympus, Fujifilm, Wision, PENTAX Medical, Wision A.I., Cybernet Systems and NEC Corporation, among 16 companies covered in total.
What geographies does the Artificial Intelligence Endoscopy System market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Artificial Intelligence Endoscopy System?
Driving factors include the increasing global demand for gastrointestinal cancer screening, rising demand for endoscopy due to aging populations, hospitals' strong demand to reduce missed diagnoses, enhanced real-time analysis capabilities brought about by improved AI chip computing power, and the gradual support of medical insurance systems for early screening of precancerous lesions.
Who should buy the Artificial Intelligence Endoscopy System market report?
The report is intended for manufacturers and solution providers, distributors and end users in Clinical, Operation and Patient Monitoring, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Artificial Intelligence Endoscopy System market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.